Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Sonoma Pharmaceuticals Inc. buy me8

Start price
€3.74
03.05.22 / 0%
Target price
€5.00
03.05.23
Performance (%)
-12.63%
End price
€3.27
14.05.22
Summary
This prediction ended on 14.05.22 with a price of €3.27. The prediction for Sonoma Pharmaceuticals Inc. disappointed with a performance of -12.63%. This prediction was marked as speculative and is excluded from me8's performance statistics.
Performance without dividends (%)
Name 1w 1m 1y
Sonoma Pharmaceuticals Inc. -12.022% -12.022% -85.127%
iShares Core DAX® 3.178% 0.980% 15.331%
iShares Nasdaq 100 2.972% 0.925% 39.831%
iShares Nikkei 225® 0.545% -4.556% 17.661%
iShares S&P 500 2.367% 0.833% 30.000%

According to me8 what are the pros and cons of Sonoma Pharmaceuticals Inc. for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Very capable Management
Very good company culture
Cons
Few uniques

Comments by me8 for this prediction

In the thread Sonoma Pharmaceuticals, Inc. diskutieren

Buy Sonoma Pharmaceuticals Inc.

Prediction Buy
Perf. (%) -12.63%
Target price 5.000
Change
Ends at 03.05.23

Kursziel gesetzt auf 5,0

In the thread Trading Sonoma Pharmaceuticals, Inc.
Prediction Buy
Perf. (%) -12.63%
Target price 5.000
Change
Ends at 03.05.23

Einschätzung wurde nach dem Ende von Catch the Monkey automatisch beendet.